What a dream team at #GATMO2025! Nico Gagelmann, Carmelo Gurnari, Queralt Salas y Mi Kwon — thank you for lighting up the room with your brilliance, kindness, and energy! We learned, laughed, and felt truly inspired. Hope to see you all back soon! 🧬✨🌎❤️ #NextGenHematology

Early-Phase Trials in Journal of Clinical Oncology on aspects of what constitutes high-quality early-phase trials with the goal of providing guidance for future JCO submissions. ascopubs.org/doi/10.1200/JC…

Out now in Blood Journal, Lu et al 🙌🏽 Phase IIb Ven/Dec vs Intensive chemo (7&3) in younger adults with AML 💪🏽 1° end point: CRc after induction ➡️CRc 89% vs 79%, non inf p=0.002 💪🏽 ➡️Ven/Dec better tolerated 🙌🏽 #MedTwitter ashpublications.org/blood/article/…

‼️ #ASCO25 simultaneous publication by Mazyar Shadman, MD MPH et al:  Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results: brnw.ch/21wT3Ph

✨ Thank you to everyone who joined #GATMO2025! 🙌 With 254 in-person and 53 virtual participants from over 15 countries 🌍, we proudly met our goals of networking and inspiring the next generation 💪🧠 Feeling very happy and grateful! ❤️ 🔗 gatmo.sahonline.com.ar

Arjun D. Law has been so much more than a mentor, more like a (tor)mentor! From medicine to life itself, he has taught me everything with humour and ruthless honesty. Grateful. Traumatised. Wouldn’t change a thing. ❤️

Peripheral blood smear of a 22 yr old male with fever and cervical lymphadenopathy! What's going on? Describe the cell 👇🏽 Ddx? Management? #MedTwitter 📸 ASH image bank

🎉Finally out🎉 Our study showed value of low dose splenic irradiation and transplantation as part of a curative approach in myelofibrosis with refractory splenomegaly: - significant spleen size reduction - excellent engraftment #mpnsm Transplantation and Cellular Therapy Journal astctjournal.org/article/S2666-…

Lovely work! Thanks Nico Gagelmann and everyone in your team! Improving management in #MF

🎉Finally out🎉 Daratumumab for post-transplant pure red cell aplasia: study and practical considerations from The EBMT Now in Blood Cancer Journal nature.com/articles/s4140…

Timely tour de force review on Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches | Journal of Clinical Oncology Toby Eyre ascopubs.org/doi/full/10.12…

Very nice and important data. Another tool for treating our patients. Congrats!!! Nico Gagelmann